The expression of CNV-amplified m6A regulators YTHDF1, YTHDF2, YTHDF3, and FTO was remarkably higher in AML specimens than in healthy specimens (Figure 1D). This evidence concerns the gene YTHDF2 and acute myeloid leukemia.